Literature DB >> 9451026

Abnormal synthesis of mannose 1-phosphate derived carbohydrates in carbohydrate-deficient glycoprotein syndrome type I fibroblasts with phosphomannomutase deficiency.

C Körner1, L Lehle, K von Figura.   

Abstract

In fibroblasts from five patients with carbohydrate-deficient glycoprotein syndrome type 1, the incorporation of [2-3H] mannose into mannose phosphates, GDP-mannose, GDP-fucose, dolichol-P-mannose, lipid-linked oligosaccharides, and glycoprotein fraction was determined. We observed a 3- to 5-fold reduction of incorporation of radioactivity into mannose 1-phosphate, GDP-mannose, GDP-fucose, dolichol-P-mannose, and nascent glycoproteins. The incorporation of radioactivity into mannose 6-phosphate was normal. The formation of lipid linked oligosaccharides was only slightly affected (</=20%), but their size was severely reduced, mostly containing five or fewer residues. As a consequence, truncated oligosaccharides were transferred to newly synthesized glycoproteins. The metabolic changes can be explained by a deficiency of phosphomannomutase activity, which was reduced to </=10% of control.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9451026     DOI: 10.1093/glycob/8.2.165

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  14 in total

1.  Improvement of dolichol-linked oligosaccharide biosynthesis by the squalene synthase inhibitor zaragozic acid.

Authors:  Micha A Haeuptle; Michael Welti; Heinz Troxler; Andreas J Hülsmeier; Timo Imbach; Thierry Hennet
Journal:  J Biol Chem       Date:  2010-12-23       Impact factor: 5.157

2.  Carbohydrate-deficient glycoprotein syndrome type V: deficiency of dolichyl-P-Glc:Man9GlcNAc2-PP-dolichyl glucosyltransferase.

Authors:  C Körner; R Knauer; U Holzbach; F Hanefeld; L Lehle; K von Figura
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

3.  Lack of phosphomannomutase 2 affects Xenopus laevis morphogenesis and the non-canonical Wnt5a/Ror2 signalling.

Authors:  Nastassja Himmelreich; Lilian T Kaufmann; Herbert Steinbeisser; Christian Körner; Christian Thiel
Journal:  J Inherit Metab Dis       Date:  2015-07-04       Impact factor: 4.982

4.  Regulation of the dolichol pathway in human fibroblasts by the endoplasmic reticulum unfolded protein response.

Authors:  W T Doerrler; M A Lehrman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

5.  Analysis of glycosylation in CDG-Ia fibroblasts by fluorophore-assisted carbohydrate electrophoresis: implications for extracellular glucose and intracellular mannose 6-phosphate.

Authors:  Ningguo Gao; Jie Shang; Mark A Lehrman
Journal:  J Biol Chem       Date:  2005-02-11       Impact factor: 5.157

6.  A novel carbohydrate-deficient glycoprotein syndrome characterized by a deficiency in glucosylation of the dolichol-linked oligosaccharide.

Authors:  P Burda; L Borsig; J de Rijk-van Andel; R Wevers; J Jaeken; H Carchon; E G Berger; M Aebi
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

7.  Deficiency of GDP-Man:GlcNAc2-PP-dolichol mannosyltransferase causes congenital disorder of glycosylation type Ik.

Authors:  Markus Schwarz; Christian Thiel; Jürgen Lübbehusen; Bert Dorland; Tom de Koning; Kurt von Figura; Ludwig Lehle; Christian Körner
Journal:  Am J Hum Genet       Date:  2004-02-16       Impact factor: 11.025

8.  Deficiency of dolichyl-P-Man:Man7GlcNAc2-PP-dolichyl mannosyltransferase causes congenital disorder of glycosylation type Ig.

Authors:  Christian Thiel; Markus Schwarz; Martin Hasilik; Ulrike Grieben; Folker Hanefeld; Ludwig Lehle; Kurt von Figura; Christian Körner
Journal:  Biochem J       Date:  2002-10-01       Impact factor: 3.857

9.  Insulin up-regulates a Glc3Man9GlcNAc2-PP-Dol pool in capillary endothelial cells not essential for angiogenesis.

Authors:  José J Tavárez-Pagán; Caroline M Oliveira; Dipak K Banerjee
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

Review 10.  Towards a therapy for phosphomannomutase 2 deficiency, the defect in CDG-Ia patients.

Authors:  Hudson H Freeze
Journal:  Biochim Biophys Acta       Date:  2009-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.